Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.2.u1
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Based Compensation

Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:

 

Stock-based compensation   2024     2023     2024     2023  
    Three Months Ended June 30,     Six Months Ended June 30,  
Stock-based compensation   2024     2023     2024     2023  
Cost of revenues   $ 49     $ 111     $ 94     $ 364  
Sales and marketing     17       35       31       132  
General and administrative     570       1,260       1,126       2,119  
Research and development     24       56       39       209  
Total stock-based compensation   $ 660     $ 1,462     $ 1,290     $ 2,824  
Schedule of Restricted Stock Unit Activity

A summary of our restricted stock unit activity for the six months ended June 30, 2024 is set forth below:

 

    Shares     Weighted Average Grant Date Fair Value  
Outstanding as of December 31, 2023     96,808     $ 25.21  
Granted     84,081       5.63  
Released     (110,570 )     11.05  
Forfeited     (48 )     46.50  
Outstanding as of June 30, 2024     70,271     $ 24.05  
Schedule of Stock Option Activity

A summary of our stock option activity under the 2018 Equity Incentive Plan (the “2018 Plan) and related information is as follows:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contractual Term

(years)

   

Aggregate

Intrinsic

Value

 
Outstanding as of December 31, 2023     2,500     $ 56.89       4.2     $  
Granted                            
Exercised                            
Forfeited                            
Outstanding as of June 30, 2024     2,500     $ 56.89       3.69     $  
Exercisable as of June 30, 2024     2,500     $ 56.89       3.69     $  

 

A summary of our option activity under our 2009 Equity Incentive Plan (the “2009 Plan”) and related information is as follows:

 

   

Number of

Shares

   

Weighted

Average

Exercise

Price

   

Weighted

Average

Remaining

Contractual Term

(years)

   

Aggregate

Intrinsic

Value

 
Outstanding as of December 31, 2023     14,625     $ 39.67       2.9     $  
Granted                            
Exercised                            
Forfeited     (8,802 )     37.06                  
Outstanding as of June 30, 2024     5,823     $ 43.62       2.97     $  
Exercisable as of June 30, 2024     5,823     $ 43.62       2.97     $